Overview
Peter Crow is a Hematologist Oncology specialist and an Oncologist in Concord, New Hampshire. Dr. Crow is rated as an Experienced provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, and Richter Syndrome.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
250 Pleasant St, Concord, NH 03301
The General Hospital Corporation
Philip Saylor is a Hematologist Oncology specialist and a Hematologist in Waltham, Massachusetts. Dr. Saylor is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Liver Embolization. Dr. Saylor is currently accepting new patients.
Dartmouth-Hitchcock Clinic
Sergey Devitskiy is a Hematologist Oncology specialist and a Hematologist in Lebanon, New Hampshire. Dr. Devitskiy is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Clear Cell Sarcoma. Dr. Devitskiy is currently accepting new patients.
New Hampshire Oncology-Hematology PA
Meredith Selleck is a Hematologist Oncology specialist and a Hematologist in Concord, New Hampshire. Dr. Selleck is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. Her top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Paget Disease of the Breast, and Lung Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Dr. Crow isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Crow isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Lung CancerDr. Crow isDistinguished. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Crow isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Crow isDistinguished. Learn about Pleuropulmonary Blastoma.
- Richter SyndromeDr. Crow isDistinguished. Learn about Richter Syndrome.
- Advanced
- Acute Eosinophilic PneumoniaDr. Crow isAdvanced. Learn about Acute Eosinophilic Pneumonia.
- AgranulocytosisDr. Crow isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Crow isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Crow isAdvanced. Learn about Angiosarcoma.
- AstrocytomaDr. Crow isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Crow isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Crow isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Crow isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Crow isExperienced. Learn about Acute Myelomonocytic Leukemia.